Colour topography

Article

The new Keratograph 5M is the perfect tool for topography and advanced external imaging for dry eye screening.

OCULUS Keratograph 5M debuts colour to topography!

The new Keratograph 5M is the perfect tool for topography and advanced external imaging for dry eye screening.

  • High-resolution colour camera and magnification changer
  • Imaging of the upper and lower meibomian glands
  • Non-invasive tear film break up time and tear meniscus height measurements
  • Assessment of the lipid layer and tear film particles
  • Grading of the bulbar redness
  • Image and video documentation

The high-resolution colour camera and the integrated magnification changer of the OCULUS Keratograph 5M offer a new perspective on the tear film assessment procedure.

The Keratograph 5M provides the ideal illumination for every application: white diodes for the assessment of tear film particles movement, blue diodes for fluorescein imaging, infrared diodes for meibography and white annular illumination is used to precisely measure thousands of points on the surface of the cornea.

In addition to these unique features the Keratograph 5M measures corneal topography precisely. The built-in real keratometer and automatic measurement activation guarantee perfect reproducibility of K values. Tear film break-up time measurement with the Keratograph 5M is touch-free and fully automatic.

Integrate the Keratograph 5M into your practice as an active patient consultation tool. Thanks to many visual maps and easy to understand diagrams the Keratograph 5M enhances communication with your patients.

Further information may be found here.

Company name: OCULUS
E-mail: export@oculus.deWebsite: www.oculus.de

Recent Videos
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
Paulo Antonio Silva, Associate Professor of Ophthalmology at Harvard Medical School
Intraocular Pressure Outcomes Following Suprachoroidal Triamcinolone Acetonide in Patients With Glaucoma, Ocular Hypertension, or Steroid Response
Durga Borkar, MD, MMCi, discusses FAS inhibition with ONL-1204
Theodore Leng, MD, MS, speaks about 12-Month Real-World Clinical and Anatomical Outcomes With Faricimab in Patients With Diabetic Macular Edema:The FARETINA-DME Study
Rishi P. Singh, MD, discussed his presentation on the results from part 1 of the Phase 2/3 SIGLEC trial assessing AVD-104 for GA
Carl C. Awh, MD, FASRS, speaks with Hattie Hayes of Ophthalmology Times Europe
Carl J. Danzig, MD
Martin Zinkernagel, MD, PhD, speaks about the ASRS sustainability expert panel
Srinivas Sai Kondapalli, MD, discusses outer retinal tubulations in lesion growth for subfoveal and non-subfoveal GA
© 2024 MJH Life Sciences

All rights reserved.